All companies, by net margin
508 companies and 2240 sets of results: the S&P 500, and sometimes a company from outside it. We can draw the statement for 418.
| # | Company | Market cap | Share price | Net margin | Quarter |
|---|---|---|---|---|---|
| Not ranked below this line: we do not hold four quarters in a row, or a quarter's bottom line is withheld because the filing's copy of it cannot be trusted, so the figure is not the same quantity as the ones above it. | |||||
| – |
|
$63.5B | $63.56 +0.9% | 9% 3 of four quarters in a row 2025: Q2, Q3, Q4 | Q4 FY25 OXY Occidental Petroleum |
| – |
|
$14.5B | $20.07 +1.6% | 9% 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 WY Weyerhaeuser |
| – |
|
$10.8B | $91.30 −2.1% | 8% 3 of four quarters in a row 2026: Q1, Q2 · 2025: Q4 | Q2 FY26 ALB Albemarle |
| – |
|
$13.7B | $180.85 −0.7% | 8% 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 AVY Avery Dennison |
| – |
|
$35.0B | $430.43 −1.7% | 8% 3 of four quarters in a row 2026: Q1, Q2 · 2025: Q4 | Q2 FY26 AXON Axon Enterprise |
| – |
|
$51.3B | $109.98 +0.0% | 8% 1 of four quarters in a row 2025: Q4 | Q4 FY25 ETR Entergy |
| – |
|
$102B | $375.22 +1.2% | 8% 1 of four quarters in a row 2026: Q3 | Q3 FY26 GD General Dynamics |
| – |
|
$104B | $478.86 +0.2% | 8% 1 of four quarters in a row 2026: Q3 | Q3 FY26 HCA HCA Healthcare |
| – |
|
$44.3B | $269.28 −2.1% | 8% 1 of four quarters in a row 2026: Q3 | Q3 FY26 IQV IQVIA |
| – |
|
$10.4B | $176.20 −0.2% | 8% 1 of four quarters in a row 2026: Q1 | Q1 FY26 UHS Universal Health Services |
| – |
|
$7.1B | $39.92 +1.8% | 7% 1 of four quarters in a row 2026: Q2 | Q2 FY26 TAP Molson Coors Beverage |
| – |
|
$57.5B | $38.76 +0.9% | 6% 3 of four quarters in a row 2026: Q1, Q2, Q3 | Q3 FY26 NKE Nike |
| – |
|
$15.5B | $102.38 −1.2% | 5% 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 SWK Stanley Black & Decker |
| – |
|
$24.6B | $34.06 +1.3% | 4% 1 of four quarters in a row 2026: Q3 | Q3 FY26 DOW Dow |
| – |
|
$48.9B | $12.26 −0.8% | 4% 1 of four quarters in a row 2026: Q3 | Q3 FY26 F Ford Motor |
| – |
|
$75.6B | $86.13 +0.5% | 4% 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 GM General Motors |
| – |
|
$42.2B | $178.95 +0.6% | 4% 1 of four quarters in a row 2026: Q2 | Q2 FY26 LYV Live Nation Entertainment |
| – |
|
$37.1B | $77.00 +1.0% | 3% 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 ADM Archer Daniels Midland |
| – |
|
$116B | $90.50 +0.2% | 3% 3 of four quarters in a row 2026: Q1, Q2 · 2025: Q4 | Q2 FY26 CVS CVS Health |
| – |
|
$91.1B | $420.19 −0.4% | 3% 2 of four quarters in a row 2026: Q2, Q3 | Q3 FY26 ELV Elevance Health |
| – |
|
$16.8B | $122.00 −0.3% | 3% 3 of four quarters in a row 2026: Q1, Q2, Q3 | Q3 FY26 GPC Genuine Parts |
| – | HUM S&P 500 Humana S&P 500 Share price: $410.33 −1.5% Q1 FY26 HUM Humana | $49.3B | $410.33 −1.5% | 3% 1 of four quarters in a row 2026: Q1 | Q1 FY26 HUM Humana |
| – |
|
$14.0B | $82.17 −1.7% | 3% 3 of four quarters in a row 2026: Q1, Q2 · 2025: Q4 | Q2 FY26 SOLV Solventum |
| – |
|
$34.3B | $181.33 +1.4% | 3% 2 of four quarters in a row 2026: Q1 · 2025: Q4 | Q1 FY26 TKO TKO |
| – |
|
$33.4B | $67.68 −1.4% | 2% 3 of four quarters in a row 2026: Q1, Q2, Q3 | Q3 FY26 CNC Centene |
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.